Hormone feminizing treatment for transgender and non-binary people
Part of Hormones & metabolism clinical trials.
This study looks at feminizing gender-affirming treatment (hormones) in transgender women and non-binary people. It may help improve how this type of treatment is provided and evaluated for safety and effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were assigned male at birth
- You are eligible for gender-affirming feminizing treatment
- You are a transgender woman or non-binary person seeking feminizing treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for transgender men who want care focused on body identity. It likely studies how testosterone treatment and clinic support affect body-related feelings and wellbeing.
This study looks at how testosterone affects the brain and reproductive hormones in people who are starting testosterone therapy and those who are not. It aims to understand the body's natural hormone cycles.
This study looks at how gender-affirming hormone therapy affects heart health, metabolism, and mental well-being in transgender adults. It aims to understand the benefits and risks to help improve care.
This study looks at how people respond early after starting gender-confirming hormones. It may help doctors understand what changes happen soon after treatment starts and how to manage it safely.
This study tests whether adding progesterone to your current hormone therapy helps transgender women feel better and more satisfied with their treatment. It might be a good fit if you've been on hormones for at least 6 months and haven't used progesterone before.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
Hear when a new Transgenderism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.